J&J Executive Compensation Details Revealed

Ticker: JNJ · Form: DEF 14A · Filed: 2025-03-12T00:00:00.000Z

Sentiment: neutral

Topics: executive-compensation, proxy-statement, annual-filing

TL;DR

J&J dropped its 2024 exec pay details - equity awards, pensions, etc. are all in the filing.

AI Summary

Johnson & Johnson filed its DEF 14A on March 12, 2025, detailing executive compensation for the fiscal year ending December 29, 2024. The filing includes information on equity awards, pension values, and changes in compensation for both principal executive officers (PEO) and non-PEO named executive officers. Specific dollar amounts and dates related to these compensation components are outlined within the document.

Why It Matters

This filing provides transparency into how Johnson & Johnson compensates its top executives, which can influence investor perception and corporate governance discussions.

Risk Assessment

Risk Level: low — This is a routine annual filing disclosing executive compensation and does not present new or unexpected risks.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a DEF 14A filing?

A DEF 14A filing, also known as a Proxy Statement, is used by companies to solicit proxies from shareholders when seeking shareholder approval for corporate actions or to elect directors.

When was Johnson & Johnson's fiscal year end for the period covered by this filing?

The fiscal year end for the period covered by this filing was December 29, 2024.

What type of compensation details are typically found in a DEF 14A?

DEF 14A filings typically detail executive compensation, including salary, bonuses, stock awards, option awards, and other benefits, as well as information on director compensation and corporate governance matters.

What is the Central Index Key (CIK) for Johnson & Johnson?

The Central Index Key for Johnson & Johnson is 0000200406.

What is the Standard Industrial Classification (SIC) code for Johnson & Johnson?

The Standard Industrial Classification code for Johnson & Johnson is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0000200406-25-000099.txt : 20250312 0000200406-25-000099.hdr.sgml : 20250312 20250312064055 ACCESSION NUMBER: 0000200406-25-000099 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 172 CONFORMED PERIOD OF REPORT: 20250312 FILED AS OF DATE: 20250312 DATE AS OF CHANGE: 20250312 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 25729938 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 DEF 14A 1 jnj-20250311.htm DEF 14A jnj-20250311 0000200406 DEF 14A FALSE iso4217:USD iso4217:USD xbrli:shares xbrli:pure 0000200406 2024-01-01 2024-12-29 0000200406 2023-01-02 2023-12-31 0000200406 2022-01-03 2023-01-01 0000200406 2021-01-04 2022-01-02 0000200406 2019-12-30 2021-01-03 0000200406 ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:AggtPnsnAdjsSvcCstMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:AggtChngPnsnValInSummryCompstnTblForAplblYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:AggtPnsnAdjsSvcCstMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:PnsnAdjsSvcCstMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:PnsnAdjsPrrSvcCstMember ecd:PeoMember 2024-01-01 2024-12-29 0000200406 ecd:PnsnAdjsSvcCstMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 ecd:PnsnAdjsPrrSvcCstMember ecd:NonPeoNeoMember 2024-01-01 2024-12-29 0000200406 1 2024-01-01 2024-12-29 0000200406 4 2024-01-01 2024-12-29 0000200406 2 2024-01-01 2024-12-29 0000200406 5 2024-01-01 2024-12-29 0000200406 3 2024-01-01 2024-12-29 0000200406 6 2024-01-01 2024-12-29 0000200406 7 2024-01-01 2024-12-29 0000200406 us-gaap:EmployeeStockOptionMember jnj:DuatoMember 2024-12-29 0000200406 us-gaap:EmployeeStockOptionMember jnj:WolkMember 2024-12-29 0000200406 us-gaap:EmployeeStockOptionMember jnj:SchmidMember 2024-12-29 0000200406 us-gaap:EmployeeStockOptionMember jnj:TaubertMember 2024-12-29 0000200406 us-gaap:EmployeeStockOptionMember jnj:ReedMember 2024-12-29 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant   ý Filed by a Party other than the Registra

View on Read The Filing